Navigating Global Regulatory Submissions: eCTD, IDMP and Emerging Requirements

Regulatory submissions are the gateway to market access, and their quality directly influences review timelines. As health authorities adopt electronic formats and structured data standards, regulatory affairs teams must manage complex dossiers across multiple regions while keeping content consistent and compliant. This white paper summarizes current expectations for the electronic Common Technical Document (eCTD), the Identification of Medicinal Products (IDMP) standards and related emerging requirements, and offers practical tips for streamlining global filings.

The Evolving Regulatory Submission Landscape

The Common Technical Document (CTD) harmonized the structure of marketing applications across ICH regions, organizing content into five modules: regional administrative information, summaries, quality, nonclinical and clinical. The electronic version, eCTD, added a standardized XML backbone, enabling lifecycle management of documents through new, replace and delete operations. Today most major regulators require or strongly prefer eCTD, and newer versions and regional variations continue to emerge.

eCTD Essentials

Structure and Granularity

Each eCTD sequence contains documents placed in a defined folder structure with metadata describing their location and lifecycle. Consistent granularity, meaning how content is split into files, supports efficient review and lifecycle updates. Using standard file naming, bookmarks and hyperlinks makes navigation straightforward for reviewers.

Publishing and Validation

Dedicated publishing software assembles documents, builds the backbone and checks technical conformance. Validation against regional criteria catches errors such as broken links, missing files and invalid formats before submission. A rigorous quality check process reduces the risk of technical rejection.

• •Maintain document templates that enforce formatting and bookmarks
• •Use controlled vocabularies and metadata consistently
• •Perform final validation using the regulator's current criteria
• •Archive submitted sequences with complete audit trail

Lifecycle Management

Post-approval changes, such as variations, supplements and annual reports, are managed through additional sequences. Maintaining an accurate cumulative view of the current dossier, and a clear record of what was submitted when, is essential for inspections and future filings.

Structured Data and IDMP

What IDMP Is

IDMP is a set of ISO standards defining how to uniquely identify and describe medicinal products, substances, pharmaceutical forms and packaging. By standardizing product data, regulators aim to improve pharmacovigilance, supply chain traceability, and cross-border information exchange.

Implementation Implications

Companies must collect, clean and govern master data for their products, often scattered across regulatory, manufacturing, safety and commercial systems. Establishing a single source of truth for product data, with clear ownership and quality processes, underpins compliance. Regional implementation timelines vary, with some regions moving earlier toward structured submission of product data.

Other Data Standards

Standards for substance identification, controlled vocabularies and structured product labeling are becoming more widespread. Preparing now by cleaning data and aligning terminology reduces future workload.

Multi-Region Submission Strategy

Core Content, Regional Adaptation

A global core dossier, particularly for quality and nonclinical content, can serve as the basis for multiple regions, with Module 1 and region-specific details adapted. Harmonizing content reduces rework and ensures consistency across filings.

Sequencing and Timelines

Strategic decisions about which regions to file first consider regulatory pathways, reliance mechanisms, market priority and review durations. Reliance and work-sharing initiatives allow some authorities to leverage assessments by others, accelerating access.

Local Requirements

Differences in labeling formats, language requirements, pharmacopeial references, stability data expectations and administrative documents must be tracked. A regulatory intelligence function keeps teams informed of changes.

Managing Quality and Efficiency

Document Authoring

High-quality source documents lead to high-quality submissions. Structured authoring, templates, content reuse and review workflows reduce inconsistency. Regulatory information management systems provide visibility into submission status, commitments and renewal dates.

Automation and Technology

Automation of publishing, validation and tracking reduces manual work. Emerging tools apply AI to assist in content consistency checks and drafting, though human oversight remains vital.

Collaboration with Partners

Contract manufacturers and development partners contribute content to dossiers. Clear agreements on timelines, formats and responsibilities avoid last-minute delays.

Emerging Requirements and Trends

Regulators are exploring next-generation formats, including structured content and data-centric submissions that go beyond document-based filings. Cloud-based submission gateways, electronic labeling and increased digital interaction with agencies continue to develop. Staying engaged with regulatory guidance and industry working groups helps companies prepare.

Practical Recommendations

• •Create a global submission calendar linking regions and milestones
• •Standardize templates, naming conventions and publishing procedures
• •Invest in master data governance for IDMP readiness
• •Perform pre-submission quality reviews and technical validation
• •Track commitments and lifecycle changes in a central system

Conclusion

Efficient, compliant regulatory submissions rely on strong processes, consistent data and the right technology. By mastering eCTD, preparing for IDMP and adopting a global yet flexible strategy, companies can reduce delays, avoid technical rejections and bring medicines to patients sooner.